151203452	151203452	CD	B-NP	O
|	|	NNP	I-NP	O
QHOV	QHOV	NNP	I-NP	O
|	|	VBD	B-VP	O
41748484	41748484	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
276315	276315	CD	B-NP	O
|	|	CC	I-NP	O
8/18/1997	8/18/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CARDIOMYOPATHY	CARDIOMYOPATHY	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/12/1997	4/12/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/16/1997	2/16/1997	CD	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
DILATED	DILATED	NN	I-NP	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HYPOTENSION	HYPOTENSION	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
RENAL	RENAL	NN	I-NP	O
FAILURE	FAILURE	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PANCREATITIS	PANCREATITIS	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Hald	Hald	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
45	45	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
reported	report	VBN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
myocarditis	myocarditis	NN	B-NP	O
approximately	approximately	RB	B-NP	O
fifteen	fifteen	CD	I-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
abuse	abuse	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
1995	1995	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Elka	Elka	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
upper	upper	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	O	O
progressive	progressive	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
cardiomegaly	cardiomegaly	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
plus	plus	CC	O	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
right	right	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
catheterization	catheterization	NN	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
dominates	dominate	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
exercise	exercise	NN	I-NP	O
treadmill	treadmill	NN	I-NP	O
test	test	NN	I-NP	O
scan	scan	NN	I-NP	O
show	show	VBP	B-VP	O
maximal	maximal	JJ	B-NP	O
VO2	VO2	NN	I-NP	O
of	of	IN	B-PP	O
12.6	12.6	CD	B-NP	O
milliliters	milliliter	NNS	I-NP	O
per	per	IN	B-PP	O
kilogram	kilogram	NN	B-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
.	.	.	O	O

More	More	RBR	B-ADVP	O
recently	recently	RB	I-ADVP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
show	show	VBP	B-VP	O
an	an	DT	B-NP	O
injections	injection	NNS	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
managed	manage	VBN	I-VP	O
on	on	IN	B-PP	O
Digoxin	Digoxin	NN	B-NP	O
,	,	,	O	O
diuretics	diuretic	NNS	B-NP	O
and	and	CC	O	O
ACE	ACE	NN	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
excretion	excretion	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sifre	Sifre	NNP	I-NP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
February	February	NNP	I-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
give	give	VB	B-VP	O
a	a	DT	B-NP	O
prescription	prescription	NN	I-NP	O
for	for	IN	B-PP	O
Zaroxolyn	Zaroxolyn	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
until	until	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
had	have	VBD	I-VP	O
brisk	brisk	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
she	she	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
mild	mild	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
without	without	IN	B-PP	O
radiation	radiation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
bleeding	bleeding	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
melena	melena	NN	I-NP	O
but	but	CC	O	O
had	have	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Rin	Rin	NNP	I-NP	B-protein
Noa	Noa	NNP	I-NP	O
Joneso	Joneso	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.3	1.3	CD	B-NP	O
.	.	.	O	O

Amylase	Amylase	NN	B-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
.	.	.	O	O

Laboratory	Laboratory	NN	B-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
glucose	glucose	NN	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
3.2	3.2	CD	B-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
number	number	NN	I-NP	O
two	two	CD	B-NP	O
and	and	CC	I-NP	O
then	then	RB	I-NP	O
subsequently	subsequently	RB	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
5.5	5.5	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
decrease	decrease	NN	B-NP	O
in	in	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
70	70	CD	I-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
urgently	urgently	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Coc	Coc	NNP	I-NP	O
Whitpa	Whitpa	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Dopamine	Dopamine	NN	I-NP	O
and	and	CC	I-NP	O
Insulin	Insulin	NN	I-NP	B-protein
drip	drip	NN	I-NP	I-protein
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Dilated	Dilate	VBN	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Adult	Adult	NN	I-NP	O
onset	onset	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
appendectomy	appendectomy	NN	B-NP	O
and	and	CC	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	O
cyst	cyst	NN	I-NP	O
removal	removal	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
Penicillin	Penicillin	NNP	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Digoxin	Digoxin	NN	I-NP	O
.375	.375	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Lasix	Lasix	NNP	I-NP	O
160	160	CD	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Captopril	Captopril	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
K-Dur	K-Dur	NNP	I-NP	O
40	40	CD	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Magnesium	Magnesium	NNP	I-NP	O
oxide	oxide	NN	I-NP	O
1	1	CD	I-NP	O
gram	gram	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Aspirin	Aspirin	NN	I-NP	O
once	once	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DiaBeta	DiaBeta	NNP	I-NP	O
10	10	CD	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
8	8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Zaroxolyn	Zaroxolyn	NNP	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
19	19	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
son	son	NN	I-NP	O
with	with	IN	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
smoker	smoker	NN	I-NP	O
and	and	CC	O	O
drinks	drink	VBZ	B-VP	O
three	three	CD	B-NP	O
glasses	glass	NNS	I-NP	O
of	of	IN	B-PP	O
Rum	Rum	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
40	40	CD	B-NP	O
on	on	IN	B-PP	O
Doppler	Doppler	NNP	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
150	150	CD	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
face	face	NN	B-NP	O
mask	mask	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
on	on	IN	B-PP	O
Dopamine	Dopamine	NN	B-NP	O
drip	drip	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
micrograms	microgram	NNS	I-NP	O
per	per	IN	B-PP	O
kilograms	kilogram	NNS	B-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
and	and	CC	O	O
Insulin	Insulin	NN	B-NP	B-protein
10	10	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
.	.	.	O	O

Heent	Heent	NN	B-NP	O
:	:	:	O	O
Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Neck	Neck	NNP	B-NP	O
:	:	:	O	O
Right	Right	NNP	B-NP	O
interna	interna	NN	I-NP	O
jugular	jugular	JJ	I-NP	O
triple-lumen	triple-lumen	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
Clear	Clear	NNP	B-NP	O
to	to	TO	B-VP	O
auscultation	auscultation	VB	I-VP	O
anteriorly	anteriorly	RB	B-ADVP	O
and	and	CC	I-ADVP	O
laterally	laterally	RB	I-ADVP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
tachycardic	tachycardic	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
diffusely	diffusely	RB	I-NP	O
tender	tender	NN	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
guarding	guarding	NN	I-NP	O
or	or	CC	I-NP	O
rebounds	rebound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
cold	cold	NN	B-NP	O
,	,	,	O	O
clammy	clammy	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
report	report	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Rineault	Rineault	NNP	I-NP	O
Emlandli	Emlandli	NNP	I-NP	O
Health	Health	NNP	I-NP	O
showed	show	VBD	B-VP	O
some	some	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
fatty	fatty	JJ	B-NP	O
infiltration	infiltration	NN	I-NP	O
and	and	CC	O	O
diffused	diffused	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
of	of	IN	B-PP	O
pancreas	pancreas	NN	B-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
infiltration	infiltration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
peripancreatic	peripancreatic	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
pseudocyst	pseudocyst	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

PA	PA	NN	B-NP	O
catheter	catheter	NN	I-NP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

PA	PA	NN	B-NP	O
catheterization	catheterization	NN	I-NP	O
readings	reading	NNS	I-NP	O
:	:	:	O	O
Pulmonary	Pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
20	20	CD	B-NP	O
,	,	,	O	O
Pulmonary	Pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
13	13	CD	I-NP	O
,	,	,	O	O
central	central	JJ	B-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
sinus	sinus	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
at	at	IN	B-PP	O
162	162	CD	B-NP	O
beats	beat	NNS	I-NP	O
per	per	IN	B-PP	O
minutes	minute	NNS	B-NP	O
.	.	.	O	O

Axis	Axis	IN	B-PP	O
35	35	CD	B-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
millimeter	millimeter	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
V4	V4	NN	B-NP	O
through	through	IN	B-PP	O
V6	V6	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
ST	ST	NN	I-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
V1	V1	NN	B-NP	O
through	through	IN	B-PP	O
V3	V3	NN	B-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
120	120	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
3.0	3.0	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
69	69	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
67	67	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
5.5	5.5	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
961	961	CD	I-NP	O
,	,	,	O	O
GAP	GAP	NN	B-NP	B-protein
33	33	CD	I-NP	I-protein
,	,	,	O	O
amylase	amylase	NN	B-NP	O
212	212	CD	I-NP	O
,	,	,	O	O
lipase	lipase	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
704	704	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-protein
9	9	CD	I-NP	I-protein
,	,	,	O	O
AST	AST	NN	B-NP	O
33	33	CD	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-cell_line
673	673	CD	I-NP	I-cell_line
,	,	,	O	O
CKMB	CKMB	NN	B-NP	B-protein
6.3	6.3	CD	I-NP	I-protein
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
709	709	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphate	phosphate	NN	I-NP	O
47	47	CD	I-NP	O
,	,	,	O	O
direct	direct	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.3	0.3	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
1.9	1.9	CD	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
protein	protein	NN	I-NP	O
64	64	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	O
2.3	2.3	CD	I-NP	O
,	,	,	O	O
globulin	globulin	NN	B-NP	B-protein
4.1	4.1	CD	I-NP	I-protein
,	,	,	O	O
calcium	calcium	NN	B-NP	O
less	less	RBR	B-VP	O
then	then	RB	I-VP	O
assayed	assay	VBN	I-VP	O
,	,	,	O	O
phosphorus	phosphorus	NN	B-NP	B-protein
6.6	6.6	CD	I-NP	I-protein
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.4	2.4	CD	I-NP	O
,	,	,	O	O
cholesterol	cholesterol	NN	B-NP	O
57	57	CD	I-NP	O
,	,	,	O	O
triglycerides	triglyceride	VBZ	B-VP	O
59	59	CD	B-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
2.1	2.1	CD	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
like	like	IN	B-PP	O
sodium	sodium	NN	B-NP	O
71	71	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.5	4.5	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
79	79	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
78	78	CD	I-NP	O
.	.	.	O	O

Calculated	Calculate	VBN	B-NP	O
FENA	FENA	NN	I-NP	O
of	of	IN	B-PP	O
fractional	fractional	JJ	B-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
2.15	2.15	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
12.19	12.19	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
41.4	41.4	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
66	66	CD	B-NP	O
.	.	.	O	O

Differential	Differential	JJ	B-NP	B-cell_type
12	12	CD	I-NP	I-cell_type
leukocytes	leukocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
11	11	CD	B-NP	O
monocytes	monocyte	NNS	I-NP	B-cell_type
,	,	,	O	O
76	76	CD	B-NP	O
neutrophils	neutrophil	NNS	I-NP	B-cell_type
,	,	,	O	O
no	no	DT	B-NP	O
eosinophils	eosinophil	NNS	I-NP	B-cell_type
,	,	,	O	O
0.3	0.3	CD	B-NP	O
basophils	basophil	NNS	I-NP	B-cell_type
.	.	.	O	O

PT	PT	NN	B-NP	B-protein
15.3	15.3	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
34.4	34.4	CD	I-NP	I-protein
,	,	,	O	O
fibrin	fibrin	NN	B-NP	B-protein
products	product	NNS	I-NP	I-protein
less	less	RBR	B-ADVP	O
then	then	RB	I-ADVP	O
0.5	0.5	CD	B-NP	O
,	,	,	O	O
fibrinogen	fibrinogen	NN	B-NP	B-protein
372	372	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.7	1.7	CD	I-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
dilated	dilated	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
vigorously	vigorously	RB	I-VP	O
hydrated	hydrate	VBN	I-VP	O
for	for	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
few	few	JJ	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
setting	set	VBG	B-VP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
increased	increase	VBN	I-NP	O
abdominal	abdominal	JJ	I-NP	O
distension	distension	NN	I-NP	O
and	and	CC	I-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
pleural	pleural	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
sudation	sudation	NN	B-NP	O
for	for	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
withdrawal	withdrawal	NN	I-NP	O
she	she	PRP	B-NP	O
required	require	VBD	B-VP	O
intubation	intubation	NN	B-NP	O
.	.	.	O	O

Throughout	Throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
admission	admission	NN	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
on	on	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
tapable	tapable	JJ	I-NP	O
fluids	fluid	NNS	I-NP	O
collection	collection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
febrile	febrile	JJ	B-ADJP	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
before	before	RB	B-ADVP	O
despite	despite	IN	B-PP	O
therapy	therapy	NN	B-NP	O
with	with	IN	B-PP	O
Ceftazidime	Ceftazidime	NN	B-NP	O
,	,	,	I-NP	O
gentamicin	gentamicin	NN	I-NP	O
,	,	,	I-NP	O
Vancomycin	Vancomycin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
intermittently	intermittently	RB	B-ADVP	O
had	have	VBD	B-VP	O
coagulate	coagulate	VB	I-VP	O
negative	negative	JJ	B-NP	O
staphylococcal	staphylococcal	JJ	I-NP	O
cultures	culture	NNS	I-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_line
lines	line	NNS	I-NP	I-cell_line
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Xanthomonas	Xanthomonas	NN	B-NP	O
maltophilia	maltophilia	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
Bactrim	Bactrim	NNP	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
transfer	transfer	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
General	General	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
usually	usually	RB	I-VP	O
linked	link	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
120	120	CD	I-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90	90	CD	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
her	her	PRP	B-NP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
for	for	IN	B-PP	O
after	after	IN	B-PP	O
load	load	NN	B-NP	O
reduction	reduction	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

With	With	IN	B-PP	O
careful	careful	JJ	B-NP	O
surveillance	surveillance	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
maintenance	maintenance	NN	B-NP	O
of	of	IN	B-PP	O
weight	weight	NN	B-NP	O
between	between	IN	B-PP	O
73	73	CD	B-NP	O
and	and	CC	I-NP	O
74	74	CD	I-NP	O
kilograms	kilogram	NNS	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
wise	wise	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
Xanthomonas	Xanthomonas	NNP	I-NP	O
infection	infection	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
chest	chest	NN	B-NP	O
PT	PT	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Diseases	Disease	NNS	I-NP	O
as	as	IN	B-SBAR	O
stated	state	VBN	B-VP	O
above	above	IN	B-PP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
plan	plan	NN	I-NP	O
to	to	TO	B-VP	O
reculture	reculture	VB	I-VP	O
if	if	IN	B-SBAR	O
her	her	PRP$	B-NP	O
fever	fever	NN	I-NP	O
spikes	spike	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
on	on	IN	B-PP	O
total	total	JJ	B-NP	O
parenteral	parenteral	JJ	I-NP	O
nutrition	nutrition	NN	I-NP	O
until	until	IN	B-SBAR	O
she	she	PRP	B-NP	O
could	could	MD	B-VP	O
tolerate	tolerate	VB	I-VP	O
a	a	DT	B-NP	O
p.o.	p.o.	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
improved	improve	VBD	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
eubolemic	eubolemic	JJ	B-ADJP	O
after	after	IN	B-PP	O
extensive	extensive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
high	high	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
decreased	decrease	VBD	I-VP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
being	be	VBG	B-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
67	67	CD	I-NP	O
kilogram	kilogram	NN	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
tachycardic	tachycardic	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
110	110	CD	I-NP	O
's	's	POS	B-NP	O
to	to	TO	B-PP	O
120	120	CD	B-NP	O
's	'	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80	80	CD	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
6.25	6.25	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Captopril	Captopril	NNP	B-NP	O
and	and	CC	O	O
thus	thus	RB	B-ADVP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Lisinopril	Lisinopril	NNP	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
resolved	resolve	VBN	B-VP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
status	status	NN	I-NP	O
stabilized	stabilize	VBD	B-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
her	her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
90	90	CD	I-NP	O
's	's	POS	B-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Gastrointestinal	Gastrointestinal	NNP	I-NP	O
:	:	:	O	O
Pancreatitis	Pancreatitis	NN	B-NP	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
lipase	lipase	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
of	of	IN	B-PP	O
302	302	CD	B-NP	O
.	.	.	O	O

Amylase	Amylase	NN	B-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
declined	decline	VBD	B-VP	O
a	a	DT	B-NP	O
nasal	nasal	JJ	I-NP	O
gastric	gastric	JJ	I-NP	O
feeding	feeding	NN	I-NP	O
tube	tube	NN	I-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
advance	advance	VB	I-VP	O
her	her	PRP$	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
suggested	suggest	VBN	B-VP	O
nutrition	nutrition	NN	B-NP	O
supplements	supplement	NNS	I-NP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
reluctant	reluctant	JJ	B-ADJP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Infectious	Infectious	NNP	I-NP	O
Diseases	Diseases	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
any	any	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Physical	Physical	NNP	I-NP	O
Condition	Condition	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
and	and	CC	I-VP	O
tolerate	tolerate	VB	I-VP	O
light	light	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
orthostatic	orthostatic	JJ	B-ADJP	O
,	,	,	O	O
dropping	drop	VBG	B-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
60	60	CD	I-NP	O
's	's	POS	B-NP	O
on	on	IN	B-PP	O
standing	stand	VBG	B-VP	O
up	up	RP	B-PRT	O
but	but	CC	O	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
orthostasis	orthostasis	NN	I-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
decreasing	decrease	VBG	B-VP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Mental	Mental	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
base	base	NN	I-NP	O
lines	line	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
lethargic	lethargic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
confused	confused	JJ	I-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBD	B-VP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
hemodynamic	hemodynamic	JJ	I-NP	O
and	and	CC	I-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
times	time	NNS	B-NP	O
three	three	CD	B-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
about	about	IN	B-PP	O
her	her	PRP	B-NP	O
wishes	wish	VBZ	B-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
Rehabilitation	Rehabilitation	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
and	and	CC	O	O
elected	elect	VBN	B-VP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
careful	careful	JJ	B-NP	O
VNA	VNA	NN	I-NP	O
and	and	CC	O	O
Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
:	:	:	O	O
Glucose	Glucose	NN	B-NP	B-protein
172	172	CD	I-NP	I-protein
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
32	32	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.7	1.7	CD	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
137	137	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.0	5.0	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
94	94	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
27	27	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
17	17	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
LDH	LDH	NN	B-NP	B-protein
230	230	CD	I-NP	I-protein
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphates	phosphate	NNS	I-NP	O
74	74	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.5	0.5	CD	I-NP	O
,	,	,	O	O
direct	direct	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
0.2	0.2	CD	I-NP	O
,	,	,	O	O
lipase	lipase	NN	B-NP	O
251	251	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
4.1	4.1	CD	I-NP	I-protein
,	,	,	O	O
calcium	calcium	NN	B-NP	B-protein
10.2	10.2	CD	I-NP	I-protein
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.4	2.4	CD	I-NP	O
,	,	,	O	O
cholesterol	cholesterol	NN	B-NP	B-protein
196	196	CD	I-NP	I-protein
,	,	,	O	O
triglycerides	triglyceride	VBZ	B-VP	O
300	300	CD	B-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
6.4	6.4	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
33.1	33.1	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
517	517	CD	B-NP	I-protein
,	,	,	O	O
PT	PT	NN	B-NP	B-cell_line
12.4	12.4	CD	I-NP	I-cell_line
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
25.6	25.6	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.1	1.1	CD	I-NP	I-protein
.	.	.	O	O

Clostrieium	Clostrieium	NN	B-NP	O
difficile	difficile	JJ	I-NP	O
toxin	toxin	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
.	.	.	O	O

Cortisol	Cortisol	NN	B-NP	O
21.2	21.2	CD	I-NP	O
,	,	,	O	O
a.m.	a.m.	RB	B-NP	O
cortisol	cortisol	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Nystatin	Nystatin	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	B-ADJP	O
,	,	,	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	SYM	O	O
Digoxin	Digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Colace	Colace	NNP	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Folate	Folate	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Lasix	Lasix	NNP	I-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Insulin	Insulin	NN	I-NP	B-protein
finger	finger	NN	I-NP	I-protein
sticks	stick	VBZ	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
with	with	IN	B-PP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
coverage	coverage	NN	I-NP	O
,	,	,	O	O
7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	O	O
Ativan	Ativan	NNP	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

for	for	IN	B-PP	O
agitation	agitation	NN	B-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
Multi-vitamin	Multi-vitamin	NN	I-NP	O
,	,	,	O	O
9	9	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Thiamine	Thiamine	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
10	10	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Lisinopril	Lisinopril	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DERICK	DERICK	NN	B-NP	O
SEIGFRIED	SEIGFRIED	VBD	B-VP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BV49	BV49	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KENNITH	KENNITH	NNP	B-NP	O
I.	I.	NNP	I-NP	O
STREETS	STREETS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
LL3	LL3	NNP	I-NP	O
QF092/4682	QF092/4682	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
47357	47357	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

ZFVLD60O1I	ZFVLD60O1I	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
3/30/97	3/30/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/19/97	2/19/97	CD	B-NP	O

